Skip to main content
Top
Published in: World Journal of Surgery 7/2016

01-07-2016 | Original Scientific Report

Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation

Authors: Noboru Harada, Ken Shirabe, Takashi Maeda, Hiroto Kayashima, Shintaro Takaki, Yoshihiko Maehara

Published in: World Journal of Surgery | Issue 7/2016

Login to get access

Abstract

Background

The aim of this study was to compare the outcome of patients with hepatocellular carcinoma (HCC), Barcelona Clinic Liver Cancer (BCLC) stages 0 and A, and portal hypertension (PHT) who underwent liver resection (LR) or radiofrequency ablation (RFA).

Methods

The study population consisted of 121 patients with PHT and HCC of BCLC stage 0 and A who underwent LR (n = 81) or RFA (n = 40). To reduce bias in patient selection, the different covariate distributions in two groups were adjusted using inverse probability treatment weighting (IPTW). The prognostic outcomes of LR- and RFA-treated patients were then analyzed.

Results

Before IPTW adjustment, the 5-year overall survival (OS) of LR and RFA patients was comparable. Five-year recurrence-free survival (RFS) was significantly better in the LR group than in the RFA group (P < 0.0001). Multivariate analysis showed that RFA was an independent predictor of worse RFS (P = 0.0004). The local recurrence rate was higher in the RFA than in the LR group, with recurrences in each group tending to be treated with the same modality as initially. After IPTW adjustment, the OS of patients in the LR and RFA groups did not significantly differ, whereas the RFS of the LR group remained significantly better than that of the RFA group (P = 0.00014). However, the RFA group had fewer postoperative complication rates and a shortened length of hospital stay.

Conclusions

By reducing postoperative complications, LR may be a treatment option for patients with BCLC stage 0 or A HCC and PHT.
Literature
1.
go back to reference Forner A, Reig ME, Bruix J et al (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30(1):61–74CrossRefPubMed Forner A, Reig ME, Bruix J et al (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30(1):61–74CrossRefPubMed
2.
go back to reference Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022CrossRefPubMedPubMedCentral Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022CrossRefPubMedPubMedCentral
3.
go back to reference Bruix J, Castells A, Rodés J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111(4):1018–1022CrossRefPubMed Bruix J, Castells A, Rodés J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111(4):1018–1022CrossRefPubMed
4.
go back to reference Llovet JM, Brú C, Bruix J (1996) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19(3):329–338CrossRef Llovet JM, Brú C, Bruix J (1996) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19(3):329–338CrossRef
5.
go back to reference Ishizawa T, Kokudo N, Makuuchi M et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134(7):1908–1916CrossRefPubMed Ishizawa T, Kokudo N, Makuuchi M et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134(7):1908–1916CrossRefPubMed
6.
go back to reference Cucchetti A, Ercolani G, Pinna AD et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250(6):922–928CrossRefPubMed Cucchetti A, Ercolani G, Pinna AD et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250(6):922–928CrossRefPubMed
8.
go back to reference Dutkowski P, Müllhaupt B, Clavien PA et al (2014) Challenges to liver transplantation and strategies to improve outcomes. Gastroenterology 148:307–323CrossRefPubMed Dutkowski P, Müllhaupt B, Clavien PA et al (2014) Challenges to liver transplantation and strategies to improve outcomes. Gastroenterology 148:307–323CrossRefPubMed
11.
go back to reference Bezerra AS, D’Ippolito G, Ahmed M et al (2005) Determination of splenomegaly by CT: is there a place for a single measurement? AJR Am J Roentgenol 184(5):1510–1513CrossRefPubMed Bezerra AS, D’Ippolito G, Ahmed M et al (2005) Determination of splenomegaly by CT: is there a place for a single measurement? AJR Am J Roentgenol 184(5):1510–1513CrossRefPubMed
12.
go back to reference Shirabe K, Takeishi K, Maehara Y et al (2011) Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg 35:1072–1084. doi:10.1007/s00268-011-1013-y CrossRefPubMed Shirabe K, Takeishi K, Maehara Y et al (2011) Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg 35:1072–1084. doi:10.​1007/​s00268-011-1013-y CrossRefPubMed
13.
go back to reference Yamashita YI, Shirabe K, Maehara Y et al (2014) Trends in surgical results of hepatic resection for hepatocellular carcinoma: 1,000 consecutive cases over 20 years in a single institution. Am J Surg 13:522–529 Yamashita YI, Shirabe K, Maehara Y et al (2014) Trends in surgical results of hepatic resection for hepatocellular carcinoma: 1,000 consecutive cases over 20 years in a single institution. Am J Surg 13:522–529
15.
go back to reference Pugh RN, Pietroni MC, Williams R et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649CrossRefPubMed Pugh RN, Pietroni MC, Williams R et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649CrossRefPubMed
16.
go back to reference Chau GY, King KL, Wu CW et al (2005) Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function. World J Surg 29(11):1374–1383. doi:10.1007/s00268-005-7766-4 CrossRefPubMed Chau GY, King KL, Wu CW et al (2005) Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function. World J Surg 29(11):1374–1383. doi:10.​1007/​s00268-005-7766-4 CrossRefPubMed
17.
go back to reference Kawamura H, Kamiyama T, Todo S et al (2008) Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol 23(8 Pt 1):1235–1241CrossRefPubMed Kawamura H, Kamiyama T, Todo S et al (2008) Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol 23(8 Pt 1):1235–1241CrossRefPubMed
18.
go back to reference Rhim H, Lim HK, Choe BK et al (2010) Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol 75(2):253–258CrossRefPubMed Rhim H, Lim HK, Choe BK et al (2010) Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol 75(2):253–258CrossRefPubMed
19.
go back to reference Waki K, Aikata H, Chayama K et al (2010) Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 25(3):597–604CrossRefPubMed Waki K, Aikata H, Chayama K et al (2010) Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 25(3):597–604CrossRefPubMed
20.
go back to reference Tajiri T, Yoshida H, Idezuki Y et al (2010) General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 22(1):1–9CrossRefPubMed Tajiri T, Yoshida H, Idezuki Y et al (2010) General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 22(1):1–9CrossRefPubMed
21.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
22.
go back to reference Rahbari NN, Garden OJ, Weitz J et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149(5):713–724CrossRefPubMed Rahbari NN, Garden OJ, Weitz J et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149(5):713–724CrossRefPubMed
23.
go back to reference Jarnagin WR (2010) Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol 17(5):1226–1233CrossRefPubMedPubMedCentral Jarnagin WR (2010) Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol 17(5):1226–1233CrossRefPubMedPubMedCentral
24.
go back to reference Qiu J, Zheng Y, Yuan Y et al (2015) Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study. Surgery 158:1235–1243CrossRefPubMed Qiu J, Zheng Y, Yuan Y et al (2015) Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study. Surgery 158:1235–1243CrossRefPubMed
26.
go back to reference Cammà C, Di Marco V, Craxì A et al (2005) Unità Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42(4):535–540CrossRefPubMed Cammà C, Di Marco V, Craxì A et al (2005) Unità Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42(4):535–540CrossRefPubMed
27.
go back to reference Roayaie S, Jibara G, Sherman M et al (2015) The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62:440–451CrossRefPubMed Roayaie S, Jibara G, Sherman M et al (2015) The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62:440–451CrossRefPubMed
28.
go back to reference Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161(4):346–350PubMed Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161(4):346–350PubMed
29.
go back to reference Fonseca AZ, Santin S, Ribeiro MA Jr et al (2014) Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors. World J Hepatol 6(3):107–113CrossRefPubMedPubMedCentral Fonseca AZ, Santin S, Ribeiro MA Jr et al (2014) Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors. World J Hepatol 6(3):107–113CrossRefPubMedPubMedCentral
30.
go back to reference Bertrand J, Caillol F, Giovannini M et al (2015) Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med 7:21–27CrossRefPubMedPubMedCentral Bertrand J, Caillol F, Giovannini M et al (2015) Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med 7:21–27CrossRefPubMedPubMedCentral
31.
go back to reference Duan C, Ma K, Bie P (2013) Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis. World J Surg Oncol 11(1):190CrossRefPubMedPubMedCentral Duan C, Ma K, Bie P (2013) Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis. World J Surg Oncol 11(1):190CrossRefPubMedPubMedCentral
Metadata
Title
Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation
Authors
Noboru Harada
Ken Shirabe
Takashi Maeda
Hiroto Kayashima
Shintaro Takaki
Yoshihiko Maehara
Publication date
01-07-2016
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 7/2016
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3465-6

Other articles of this Issue 7/2016

World Journal of Surgery 7/2016 Go to the issue